Intelligent Bio Solutions (INBS) Projected to Release Earnings on Monday

Intelligent Bio Solutions (NASDAQ:INBS) is expected to be releasing its Q4 2026 results before the market opens on Monday, August 17th. Analysts expect the company to announce earnings of ($1.58) per share and revenue of $1.22 million for the quarter. Interested persons may visit the the company’s upcoming Q4 2026 earning overview page for the latest details on the call scheduled for Thursday, August 20, 2026 at 4:30 PM ET.

Intelligent Bio Solutions (NASDAQ:INBS) last announced its quarterly earnings results on Wednesday, May 13th. The company reported ($1.80) earnings per share for the quarter, missing analysts’ consensus estimates of $1.40 by ($3.20). Intelligent Bio Solutions had a negative return on equity of 176.09% and a negative net margin of 296.73%.The firm had revenue of $1.06 million for the quarter, compared to the consensus estimate of $7.20 million. On average, analysts expect Intelligent Bio Solutions to post $-3 EPS for the current fiscal year and $-5 EPS for the next fiscal year.

Intelligent Bio Solutions Stock Down 7.7%

Shares of INBS stock opened at $2.77 on Friday. Intelligent Bio Solutions has a 12-month low of $1.52 and a 12-month high of $24.90. The firm has a fifty day moving average of $2.14 and a 200-day moving average of $3.26. The firm has a market capitalization of $6.63 million, a price-to-earnings ratio of -0.23 and a beta of 4.21.

Wall Street Analyst Weigh In

Several research analysts have weighed in on INBS shares. Weiss Ratings reiterated a “sell (e+)” rating on shares of Intelligent Bio Solutions in a report on Friday, July 17th. Wall Street Zen downgraded Intelligent Bio Solutions from a “hold” rating to a “sell” rating in a report on Saturday, May 2nd. Finally, Zacks Research raised Intelligent Bio Solutions to a “hold” rating in a research report on Monday, June 29th. One research analyst has rated the stock with a Hold rating and one has given a Sell rating to the stock. According to MarketBeat, the company currently has an average rating of “Reduce”.

Institutional Inflows and Outflows

An institutional investor recently bought a new stake in Intelligent Bio Solutions stock. ADAR1 Capital Management LLC acquired a new position in shares of Intelligent Bio Solutions Inc. (NASDAQ:INBS) during the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund acquired 426,433 shares of the company’s stock, valued at approximately $435,000. ADAR1 Capital Management LLC owned about 4.70% of Intelligent Bio Solutions at the end of the most recent reporting period. 32.97% of the stock is currently owned by hedge funds and other institutional investors.

About Intelligent Bio Solutions

Intelligent Bio Solutions, Inc, through its wholly owned subsidiary, is focused on the design, development and marketing of rapid, real-time detection and identification systems for foodborne and environmental pathogens. The company’s flagship product, the RAPID-B System, integrates patented biosensor and fluorescence technologies to detect viable microorganisms in a fraction of the time required by traditional culture-based testing methods. This approach enables food processors, beverage producers, environmental testing laboratories and homeland security agencies to identify contaminants such as Escherichia coli O157:H7, Salmonella spp.